Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
(NASDAQ:SNSE) BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-gener...
11 days ago